SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVIGEN(avgn)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (33)5/29/1997 7:44:00 AM
From: Tom M   of 228
 
Baird, this stock has the plague. Now it doesn't even move on patent & technology announcements. I'd like to see some insider buying that would alieve the management concerns I share with you. Seems they picked the wrong underwriters to offer this stock as it would have to double now, just to break even at its IPO. Tucker Anthony's newsletter last year had targeted this for about 12 by August & that means trippling in 3 months. If you look at the yearly stock chart showing a steady down trend, 12 in 3 months is a lot to ask now. It would take a partnership announcement AND a good level of insider buying, IMO. To add one other positive to your list, they'd like to have another stock offerring in the spring & there's no way they'll find buyers for that unless they start working on adding some shareholder value to their IPO.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News